Clinical Trials
2 trialsNCT05538897 2026-05-13
Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
National Cancer Institute (NCI)
Phase 1/2 Active not recruiting
NCT03018249 2021-11-16
Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Completed